LKFT · Lakefront Biotherapeutics NV
$27.31
-0.34 (-1.21%)
At close · Jul 31
Market Cap
$1.81B
Shares
65.48M
Lakefront Biotherapeutics NV Earnings Call Transcripts
Every quarterly earnings call for Lakefront Biotherapeutics NV (LKFT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY25 · Q4
2025-12-31
Lakefront Biotherapeutics NV Q4 FY2025 Earnings Call
Positive tone
Cash position and capital allocation
Gilead collaboration and OLCA
Strategic transformation and pivot away from cell therapy
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Lakefront Biotherapeutics NV Q3 FY2025 Earnings Call
Cautious tone
Gilead Collaboration
Jyseleca Royalties
Cell Therapy Wind-Down
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-24
Lakefront Biotherapeutics NV Q1 FY2025 Earnings Call
Positive tone
SpinCo separation and leadership transition
Cell therapy pipeline and clinical progress
Partnerships and external collaborators
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-08
Lakefront Biotherapeutics NV Q4 FY2024 Earnings Call
Confident tone
Cell therapy pipeline and CD19 CAR-T (GLPG5101 / ATALANTA)
Planned separation into Galapagos and SpinCo
Decentralized manufacturing platform (Cocoon / DMU)
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Lakefront Biotherapeutics NV Q3 FY2024 Earnings Call
Positive tone
CAR-T cell therapy pipeline and decentralized manufacturing
Clinical trial timelines and data readouts
Pipeline expansion and discovery portfolio
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Lakefront Biotherapeutics NV Q2 FY2024 Earnings Call
Positive tone
Cell therapy pipeline progress (5101, 5201)
Adaptimmune collaboration / uza-cel
BCMA / 5301 Parkinsonism safety event
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-28
Lakefront Biotherapeutics NV Q1 FY2024 Earnings Call
Positive tone
Pipeline and R&D strategy
Regulatory milestones (IND submissions)
Cell therapy programs (5101, 5201, 5301)
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Lakefront Biotherapeutics NV Q4 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Lakefront Biotherapeutics NV Q3 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Lakefront Biotherapeutics NV Q2 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Lakefront Biotherapeutics NV Q1 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Lakefront Biotherapeutics NV Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Lakefront Biotherapeutics NV Q3 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Lakefront Biotherapeutics NV Q2 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Lakefront Biotherapeutics NV Q1 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Lakefront Biotherapeutics NV Q4 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Lakefront Biotherapeutics NV Q3 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Lakefront Biotherapeutics NV Q2 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Lakefront Biotherapeutics NV Q1 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Lakefront Biotherapeutics NV Q4 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-27
Lakefront Biotherapeutics NV Q3 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Lakefront Biotherapeutics NV Q2 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Lakefront Biotherapeutics NV Q1 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–23 of 23 earnings calls
Key facts
CIK
1421876
CUSIP
36315X101
13F (30d)
18 filings
16 filers
Visit website
Investor relations